Schedule 13D ownership disclosure

EXELIXIS INC COM

Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 30161Q104

Event date: 2025-05-16

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Farallon Capital Partners, L.P.Reported CIK 0001175707

    Shares: 1,537,955 · Class: 0.6%

  • Farallon Capital Institutional Partners, L.P.Reported CIK 0000886687

    Shares: 1,843,011 · Class: 0.7%

  • Farallon Capital Institutional Partners II, L.P.Reported CIK 0001245628

    Shares: 516,264 · Class: 0.2%

  • Farallon Capital Institutional Partners III, L.P.Reported CIK 0001245629

    Shares: 254,155 · Class: 0.1%

  • Four Crossings Institutional Partners V, L.P.Reported CIK 0001690212

    Shares: 334,531 · Class: 0.1%

  • Farallon Capital Offshore Investors II, L.P.Reported CIK 0001340990

    Shares: 3,195,280 · Class: 1.2%

  • Farallon Capital (AM) Investors, L.P.Reported CIK 0001501082

    Shares: 179,796 · Class: 0.1%

  • Farallon Capital F5 Master I, L.P.Reported CIK 0001643763

    Shares: 644,314 · Class: 0.2%

  • Farallon Healthcare Partners Master, L.P.Reported CIK 0001871852

    Shares: 10,130,194 · Class: 3.7%

  • Farallon Partners, L.L.C.Reported CIK 0001040153

    Shares: 17,991,186 · Class: 6.6%

  • Farallon Institutional (GP) V, L.L.C.

    Shares: 334,531 · Class: 0.1%

  • Farallon F5 (GP), L.L.C.

    Shares: 644,314 · Class: 0.2%

  • Farallon Healthcare Partners (GP), L.L.C.

    Shares: 10,130,194 · Class: 3.7%

  • Dapice Joshua J.Reported CIK 0001960821

    Shares: 18,635,500 · Class: 6.8%

  • Dreyfuss, Philip D.Reported CIK 0001693981

    Shares: 18,635,500 · Class: 6.8%

  • Dunn Hannah E.Reported CIK 0001960890

    Shares: 18,635,500 · Class: 6.8%

  • Fried, Richard BReported CIK 0001245637

    Shares: 18,635,500 · Class: 6.8%

  • Gehani, Varun N.Reported CIK 0001904298

    Shares: 18,635,500 · Class: 6.8%

  • Giauque, NicolasReported CIK 0001372970

    Shares: 18,635,500 · Class: 6.8%

  • Kim, David T.Reported CIK 0001595643

    Shares: 18,635,500 · Class: 6.8%

  • Linn, Michael G.Reported CIK 0001495856

    Shares: 18,635,500 · Class: 6.8%

  • Luo Patrick (Cheng)Reported CIK 0002054041

    Shares: 18,635,500 · Class: 6.8%

  • Patel, Rajiv A.Reported CIK 0001275110

    Shares: 18,635,500 · Class: 6.8%

  • Roberts, Jr., Thomas G.Reported CIK 0001453042

    Shares: 18,635,500 · Class: 6.8%

  • Saito Edric C.Reported CIK 0001960819

    Shares: 18,635,500 · Class: 6.8%

  • Seybold, WilliamReported CIK 0001693980

    Shares: 18,635,500 · Class: 6.8%

  • Short Daniel S.Reported CIK 0001960871

    Shares: 18,635,500 · Class: 6.8%

  • Spokes, Andrew J. M.Reported CIK 0001372968

    Shares: 18,635,500 · Class: 6.8%

  • Warren, John R.Reported CIK 0001509711

    Shares: 18,635,500 · Class: 6.8%

  • Wehrly, Mark C.Reported CIK 0001245635

    Shares: 18,635,500 · Class: 6.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000908834-25-000192
Form type
SCHEDULE 13D/A
Filer
EXELIXIS, INC.
CIK
CIK 939767
Filed
May 20, 2025
Reporting period
May 16, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub